IC 303-2024: Patellofemoral Joint Preservation: A Case-Based Approach to Managing Chondrosis
Image For Activity Cover
Availability
On-Demand
Expires on Sep 30, 2027
Cost
Member: $20.00
Resident/Fellow Member: $20.00
Affiliate Member: $20.00
Non-Member: $30.00
Credit Offered
1.5 CME Credits
1.5 Category A CEU Credits
  • Course Information
  • ADDITIONAL INFORMATION

This course includes the recording of a live Instructional Course from the 2024 AOSSM Annual Meeting which took place in Denver, CO.

IC 303: Patellofemoral Joint Preservation: A Case-Based Approach to Managing Chondrosis

Course Description:

This roundtable ICL will provide a comprehensive approach to patellofemoral joint preservation. Expert faculty will engage participants using a variety of cases that focus on the management of patellofemoral chondrosis. The moderators will present 3-5 total cases. Each case will stimulate small group discussion to formulate a problem list and surgical plan. The moderators will then present their approach in multimedia format (i.e., surgical video), provide outcome scores, and evidence-based recommendations. Strong emphasis will be placed on dynamic group discussion.

Topics covered within patellofemoral joint preservation include cartilage restoration with or without bony realignment (i.e., TTO) and soft tissue stabilization (i.e., MPFL/LRL), Indications and techniques for cartilage restoration include chondroplasty, OAT autograft, juvenile particulated allograft, MACI, osteochondral allograft, and patellofemoral arthroplasty. Our goal is to provide participants the opportunity to engage renowned patellofemoral experts in an informal setting to gain confidence in managing these challenging cases.

Learning Objectives:

By the end of this course, participants should be able to:
  • Evaluate patellofemoral chondrosis cases.
  • Formulate rational treatment plan.
  • When and how to add soft tissue and bony procedures.
  • Rehabilitation and return to activity.
  • Review current evidence.


Faculty:

  • Seth L. Sherman, MD
  • Elizabeth A. Arendt, MD
  • David R. Diduch, MD
  • John P. Fulkerson, MD
  • Andreas Gomoll, MD
  • Christian M. Lattermann, MD
  • Beth E. Shubin Stein, MD
  • Sabrina Strickland, MD
  • Miho Tanaka, MD, PhD
  • Adam B. Yanke, MD, PhD
Accreditation

ACCREDITATION STATEMENT The American Orthopaedic Society for Sports Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Information

AMA CREDIT DESIGNATION STATEMENT The American Orthopaedic Society for Sports Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CLAIMING CREDIT In order to obtain AMA PRA Category 1 Credits™ participants must complete the activity and evaluation. Please note that this is an online-only activity. Participants must complete the activity and evaluation online. No hard copy submissions will be accepted.

ABOS MOC CREDIT STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.

The American Orthopaedic Society for Sports Medicine (AOSSM) (BOC AP#: P460) is approved by the Board of Certification, Inc. to provide continuing education for Athletic Trainers. This live activity is eligible for a maximum of 1.5 Category A hours/CEUs. ATs should claim only those hours actually spent in the educational program.

 

Disclosures
Name Disclosure Details
Arendt, Elizabeth (MD) Paid Consultant relationship with Smith and Nephew
Diduch, David (MD) Paid Consultant relationship with Depuy Synthes; Royalties relationship with Smith and Nephew; Research Support relationship with Enovis; Research Support relationship with Moximed; Research Support relationship with Moximed; Research Support relationship with DJO; Research Support relationship with Aesculap; Royalties relationship with Smith and Nephew; Paid Consultant relationship with Depuy Synthes
Fulkerson, John (MD) No Relevant Financial Relationships
Gomoll, Andreas (MD) No Relevant Financial Relationships
Lattermann, Christian (MD) Paid Consultant relationship with Vericel; Paid Consultant relationship with Organogenesis; Paid Consultant relationship with Aesculap; Research Support relationship with JRF; Stock or Stock Options relationship with Arcuro
Sherman, Mark (MD) Royalties, Financial or Material Support from Publishers relationship with springer; Royalties relationship with inomed
Shubin Stein, Beth (MD) Research Support relationship with ConMed; Paid Consultant relationship with Arthrex
Strickland, Sabrina (MD) Stock or Stock Options relationship with Moximed; Research Support relationship with Vericel; Research Support relationship with Miach Orthopaedics; Stock or Stock Options relationship with Stryker; Speaker's Bureau/Presenter relationship with Moximed; Stock or Stock Options relationship with Engage; Paid Consultant relationship with Moximed; Paid Consultant relationship with Vericel; Speaker's Bureau/Presenter relationship with Miach Orthopaedics; Paid Consultant relationship with Smith and Nephew Inc.; Paid Consultant relationship with Miach Orthopaedics; Speaker's Bureau/Presenter relationship with Smith and Nephew Inc.; Speaker's Bureau/Presenter relationship with Vericel
Tanaka, Miho (MD, PhD) Paid Consultant relationship with Arthrex; Paid Consultant relationship with Vericel; Paid Consultant relationship with depuy mitek; Research Support relationship with fujifilm
Yanke, Adam (MD, PhD) No Relevant Financial Relationships

 


In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.

ORIGINAL RELEASE DATE: 10/01/2024
EXPIRATION DATE: 09/30/2027

Android App Download IOS App Download Powered By